Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 2,330 | 2,160 | 2,048 | 1,682 | 1,097 |
| Cost of Goods | 1,502 | 1,035 | 1,297 | 1,086 | 642 |
| Gross Profit | 828 | 1,126 | 752 | 595 | 456 |
| Operating Expenses | 1,413 | 968 | 1,356 | 830 | 1,404 |
| Operating Income | -83 | 192 | -308 | -149 | -307 |
| Interest Expense | 186 | 186 | 186 | 186 | 184 |
| Other Income | -14 | -14 | -18 | -18 | -9 |
| Pre-tax Income | -283 | -7 | -512 | -352 | -499 |
| Net Income Continuous | -283 | -7 | -512 | -352 | -499 |
| Net Income | $-283 | $-7 | $-512 | $-352 | $-499 |
| EPS Basic Total Ops | -0.06 | 0.00 | -0.05 | -0.14 | -0.14 |
| EPS Basic Continuous Ops | -0.06 | 0.00 | -0.10 | -0.07 | -0.10 |
| EPS Diluted Total Ops | -0.06 | 0.00 | -0.05 | -0.14 | -0.14 |
| EPS Diluted Continuous Ops | -0.06 | 0.00 | -0.10 | -0.07 | -0.10 |
| EBITDA(a) | $-9 | $265 | $-230 | $-80 | $-259 |